At the American Chemical Society National Meeting in Philadelphia, the BioIT Group, a division of Fujitsu America, Inc., which is a wholly-owned subsidiary of global IT giant Fujitsu Limited , announced that starting today, it would be known as the BioSciences Group. "The BioSciences Group is not purely an IT organization. Our goal is to make research more effective -- not just to 'sell boxes,'" said Mr. Yasunori Katsumata, Vice President of Fujitsu America and head of the BioSciences Group. "We are a scientific solutions provider leveraging IT to solve problems for experimental scientists. Our objective is to enable researchers to reduce the trial-and-error guesswork of experimentation by introducing sophisticated automation and modeling capabilities." Dr. Michael J. McManus, Vice President of Fujitsu America's BioSciences Group said, "The solutions offered by the BioSciences Group are designed for use by the experimenters themselves -- not by IT experts -- to increase end-user productivity. We provide integrated hardware and software computational tools that allow researchers to 'experiment by design,' whether through predictive modeling and simulations, automatic ligand docking calculations, or any one of several possible solution pathways."